Barth syndrome: TAZ gene mutations, mRNAs, and evolution
- 25 March 2005
- journal article
- research article
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 134A (4) , 409-414
- https://doi.org/10.1002/ajmg.a.30661
Abstract
Barth syndrome (MIM 302060) is an X-linked condition that includes dilated cardiomyopathy, neutropenia, failure to thrive, abnormal mitochondria, and 3-methylglutaconic aciduria. The mutated gene, TAZ, first described in 1996, appeared to produce a large set of alternatively spliced mRNAs with initiations of transcription upstream of exons 1 and 3. Since then, disease-causing mutations have been found in all exons including, most recently, a missense mutation in the controversial exon 5. Because of the initially described second initiation of transcription in intron 2, with in-frame initiation of translation in exon 3, we hypothesized that subjects with mutations in exons 1 and 2 would produce more normal “short product” that might attenuate their phenotype. Moreover, it was of interest to determine which splice variants were potentially functional as exon 5 is not present in yeast and rodents, and the variant lacking this exon is the most abundant. Using RT-PCR, we characterized TAZ mRNAs in cultured lymphocytes from nine subjects with Barth syndrome and two healthy controls. The TAZ genes and mRNAs of primates were also included. We found the following: (1) there is only one site for initiation of transcription, and the normal alternatively spliced assortment is limited to full-length, Δ5, Δ7, Δ5Δ7; (2) there are two alternative splice sites within introns 1 and 2 that could potentially produce an in-frame product; (3) exon 5 evolved into “exonhood” in the primate lineage after the split between Old World monkeys and hominoid primates; and (4) our results suggest that only two functional protein variants exist in lymphocytes: Δ5 and full-length. Although exon 5 does not appear to be required for TAZ function in yeast and monkeys, its evolution to a highly conserved spliced exon in hominoid primates and the recent finding of an exon 5 mutation in a patient with Barth syndrome suggest that the full-length variant is important to TAZ function.Keywords
This publication has 11 references indexed in Scilit:
- X‐linked cardioskeletal myopathy and neutropenia (Barth syndrome): An updateAmerican Journal of Medical Genetics Part A, 2004
- Remodeling of Cardiolipin by Phospholipid TransacylationJournal of Biological Chemistry, 2003
- Only One Splice Variant of the Human TAZ Gene Encodes a Functional Protein with a Role in Cardiolipin MetabolismPublished by Elsevier ,2003
- Cardiolipin deficiency in x-linked cardioskeletal myopathy and neutropenia (barth syndrome, mim 302060): a study in cultured skin fibroblastsThe Journal of Pediatrics, 2002
- Deficiency of tetralinoleoyl‐cardiolipin in Barth syndromeAnnals of Neurology, 2002
- A novel intronic mutation of the TAZ ( G4.5 ) gene in a patient with Barth syndrome: creation of a 5' splice donor site with variant GC consensus and elongation of the upstream exonHuman Genetics, 2001
- Defective Remodeling of Cardiolipin and Phosphatidylglycerol in Barth SyndromeBiochemical and Biophysical Research Communications, 2000
- A novel X-linked gene, G4.5. is responsible for Barth syndromeNature Genetics, 1996
- X-linked dilated cardiomyopathy with neutropenia, growth retardation, and 3-methylglutaconic aciduriaThe Journal of Pediatrics, 1991
- An X-linked mitochondrial disease affecting cardiac muscle, skeletal muscle and neutrophil leucocytesJournal of the Neurological Sciences, 1983